Date/Time
Date(s) - 15 Apr 2026 until 16 Apr 2026
8:00 AM - 9:00 PM
Location
Westin La Paloma Resort
The 22nd annual Tucson Symposium, held in Tucson, Arizona, is hosted by Roche and brings together top cancer experts and thought leaders from around the world to discuss discoveries and innovations that drive advancements in pathology and oncology to improve patient screening, diagnosis, care and outcomes and shape the future of cancer medicine.
April 14-15, 2026
Weston La Paloma, Tucson, AZ
Join us in Tucson, Arizona in April 2026 when we will explore a diverse range of topics, including advances in artificial intelligence in cancer medicine and technologies, multimodal approaches for cancer screening, market access, policy and patient advocacy, next generation cancer therapies, translational pathways and the evolving role of Measurable Residual Disease (MRD) in cancer management — all with the singular focus of improving the lives of patients living with cancer.
Who attends the Tucson Symposium?
- Thought leaders wanting to share new ideas and scientific achievements in cancer research and medical practice
- Pathologists striving to keep their practices on the leading edge of technology and eager to learn more about state-of-the-art trends in diagnostics and treatment therapies
- Oncologists and pathologists wanting to hear about the newest proposed therapies and the most current diagnostic, prognostic and predictive medical findings
- Research and academic scientists who are leading the efforts in scientific discovery and are interested in forging scientific partnerships
- Strategic and scientific senior management from the healthcare industry